Keyword

SR9009

Description: A synthetic chemical compound that acts as an agonist of REV-ERB nuclear receptors and is investigated in pharmacology and cancer research.
Wikidata ID: wiki/Q15410184
OpenAlex ID: keywords/sr9009
2012 · Han Cho, Xuan Zhao, et al. · Nature · 1,192
2012 · Laura A. Solt, Yongjun Wang, et al. · Nature · 912
2018 · Shuai Wang, Yanke Lin, et al. · Nature Communications · 398
2019 · Percy Griffin, Julie M. Dimitry, et al. · Proceedings of the National Academy of Sciences · 289
2020 · Joan Chang, Richa Garva, et al. · Nature Cell Biology · 220
2019 · Pieterjan Dierickx, Matthew J. Emmett, et al. · Proceedings of the National Academy of Sciences · 182
2020 · Hui Liu, Yuanli Zhu, et al. · Cell Death and Disease · 149
2017 · Faisal J. Alibhai, Jonathan LaMarre, et al. · Journal of Molecular and Cellular Cardiology · 134
2017 · Sarbani Ghoshal, Joseph R. Stevens, et al. · Molecular Metabolism · 104
2021 · Fangjun Yu, Zhigang Wang, et al. · Nature Communications · 100
2015 · Sadichha Sitaula, Cyrielle Billon, et al. · Biochemical and Biophysical Research Communications · 91
2019 · Paula M. Wagner, Natalia M. Monjes, et al. · ASN NEURO · 69
2023 · Qixin Wang, Isaac Kirubakaran Sundar, et al. · Nature Communications · 57
Works count: 191
Citation count: 7,107
Year
Topic
Type